FOLH1 and sarcoma: PSMA expression was found to be confined to the neovasculature in sarcoma, and the frequency of positivity, defined as PSMA labelling index 1 (“low expression group”) and 2 (“strong expression group”), was highly variable among sarcoma subtypes (Table 1).